Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MS
MS logo

MS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Morgan Stanley (MS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
222.040
1 Day change
-0.03%
52 Week Range
230.470
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Morgan Stanley is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 ready to deploy immediately. The stock has solid business momentum and shareholder-friendly actions, but the current setup is mixed: technicals are neutral-to-soft, options sentiment is cautious, and the latest analyst action turned negative even though most recent target revisions were constructive. My direct view is HOLD, not BUY, at this moment.

Technical Analysis

MS closed at 214.4 after a modest gain, sitting just below the pivot level of 218.256 and above support at 209.183. MACD histogram is negative at -1.957, RSI_6 is neutral at 46.32, and moving averages are converging, which points to a sideways to slightly weak near-term trend rather than a strong breakout. The stock has some room to rebound toward resistance at 227.328, but current momentum does not confirm a clean entry.

Options Data

Bearish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Options positioning is cautious. Put-call ratios above 1 on both open interest and volume indicate more bearish-to-defensive positioning than bullish conviction. IV is elevated with IV percentile at 87.3 and IV rank at 62.6, so the market is pricing in meaningful expectations. Volume is below recent averages, suggesting no strong fresh catalyst-driven call buying.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
8

Positive Catalysts

    • Morgan Stanley passed the Federal Reserve stress tests.
    • The company announced a 15% dividend increase.
    • Management reauthorized a $20 billion stock buyback plan.
    • Recent analyst comments earlier in the cycle were constructive on trading and wealth management strength.
    • The firm appears to be benefiting from strong trading activity and resilient wealth management performance.

Neutral/Negative Catalysts

    • Oppenheimer downgraded MS to Underperform on 2026-06-30, citing valuation concerns.
    • The stock is not showing strong technical momentum; MACD remains negative and RSI is neutral.
    • Options sentiment is defensive with a 1.5 put-call OI ratio.
    • Short-term pattern analysis suggests a 60% chance of a down move over the next day and week.
    • The market overall was slightly weak, with the S&P 500 down 0.13% on the day.

Financial Performance

The latest quarter mentioned is Q2 2026, with earnings scheduled for 2026-07-15, so there is no reported quarter financial snapshot included in the data. However, the news and analyst commentary indicate strong trading and investment banking performance expectations, plus solid wealth management results. Recent commentary also pointed to 31% core wealth management pre-tax margin, 27% core ROTCE, and a 64.6% core efficiency ratio in the prior quarter, which supports a picture of solid operational execution.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst trends are mixed but generally positive before the latest downgrade. Citi raised its target to $220 and kept Neutral, JPMorgan raised its target to $187 and kept Neutral, Barclays raised its target to $230 and kept Overweight, BofA raised its target to $225 and kept Buy, Wells Fargo raised its target to $200 and kept Equal Weight, and Goldman Sachs raised its target to $205 and kept Neutral. However, Oppenheimer downgraded MS to Underperform on 2026-06-30, making the latest rating direction negative. Wall Street overall is still constructive on earnings power, trading, and wealth management, but valuation concerns are becoming more prominent.

Wall Street analysts forecast MS stock price to fall
14 Analyst Rating
Wall Street analysts forecast MS stock price to fall
7 Buy
7 Hold
0 Sell
Moderate Buy
Current: 222.100
sliders
Low
132
Averages
185
High
219
Current: 222.100
sliders
Low
132
Averages
185
High
219
BofA
Buy
maintain
$225 -> $250
AI Analysis
2026-07-07
New
Reason
BofA
Price Target
$225 -> $250
AI Analysis
2026-07-07
New
maintain
Buy
Reason
BofA raised the firm's price target on Morgan Stanley to $250 from $225 and keeps a Buy rating on the shares. All eight big banks have the potential to exceed EPS expectations and drive positive 2H26/FY27 revisions, with upside from stronger net interest income and wealth management flows likely to be rewarded despite elevated expectations, the analyst tells investors in a research note.
UBS
Buy
maintain
$214 -> $255
2026-07-07
New
Reason
UBS
Price Target
$214 -> $255
2026-07-07
New
maintain
Buy
Reason
UBS raised the firm's price target on Morgan Stanley to $255 from $214 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MS
Unlock Now

People Also Watch